5 Best Undervalued Stocks to Buy Now

4. Bio-Rad Laboratories, Inc. (NYSE: BIO)

P/E Ratio as of June 14: 4.43
Number of Hedge Fund Holders: 44

Bio-Rad Laboratories, Inc. (NYSE:BIO) ranks 4th on the list of 10 best undervalued stocks to buy now. The California-based manufacturer of technological products specializing in life science offers its services to over 35 countries in the United States. Last year, the company purchased single-cell examinator Celsee, Inc. The acquisition broadens the company’s cutting-edge products and technology to meet the growing demand of the market.

Bio-Rad Laboratories, Inc. (NYSE:BIO) posted its net sales of $726.8 billion in the first quarter of 2021, a 27.1% increase from $571.6 billion in the first quarter of 2020. BIO shares currently trade for $601.68 and have a P/E ratio of 4.43. The 52-week price range of Bio-Rad Laboratories, Inc. (NYSE:BIO) is $425.43-689.00 Shares of BIO jumped 34% over the last three months. On February 12, Citigroup maintained a Buy rating on Bio-Rad Laboratories and raises the price target to $750.

There were 44 hedge funds that reported owning stakes in Bio-Rad Laboratories, Inc. (NYSE:BIO) at the end of the first quarter, up from 42 funds a quarter earlier. The total value of these stakes at the end of Q1 is $890 million.